- Home
- RNAC vs TKNO Comparison
RNAC vs TKNO Comparison
Compare RNAC & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- TKNO
- Stock Information
- Founded
- RNAC 2007
- TKNO 1996
- Country
- RNAC United States
- TKNO United States
- Employees
- RNAC N/A
- TKNO N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- RNAC Health Care
- TKNO Health Care
- Exchange
- RNAC Nasdaq
- TKNO Nasdaq
- Market Cap
- RNAC 428.2M
- TKNO 390.7M
- IPO Year
- RNAC 2016
- TKNO 2021
- Fundamental
- Price
- RNAC $19.29
- TKNO $8.07
- Analyst Decision
- RNAC Strong Buy
- TKNO Buy
- Analyst Count
- RNAC 8
- TKNO 2
- Target Price
- RNAC $41.67
- TKNO $5.00
- AVG Volume (30 Days)
- RNAC 136.8K
- TKNO 324.6K
- Earning Date
- RNAC 03-06-2025
- TKNO 03-10-2025
- Dividend Yield
- RNAC N/A
- TKNO N/A
- EPS Growth
- RNAC N/A
- TKNO N/A
- EPS
- RNAC N/A
- TKNO N/A
- Revenue
- RNAC $47,938,000.00
- TKNO $36,347,000.00
- Revenue This Year
- RNAC $56.02
- TKNO $3.47
- Revenue Next Year
- RNAC N/A
- TKNO $12.07
- P/E Ratio
- RNAC N/A
- TKNO N/A
- Revenue Growth
- RNAC N/A
- TKNO N/A
- 52 Week Low
- RNAC $11.67
- TKNO $1.16
- 52 Week High
- RNAC $41.87
- TKNO $9.72
- Technical
- Relative Strength Index (RSI)
- RNAC 53.24
- TKNO 49.91
- Support Level
- RNAC $18.27
- TKNO $7.15
- Resistance Level
- RNAC $20.12
- TKNO $8.53
- Average True Range (ATR)
- RNAC 1.25
- TKNO 0.75
- MACD
- RNAC 0.20
- TKNO -0.14
- Stochastic Oscillator
- RNAC 77.69
- TKNO 38.06
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.